?

Beattie Nell

CFO, Head of Corp. Development
VBI Vaccines Inc.
US, Cambridge [HQ]
CIK 1702699

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
68,200
Price per Share :
$0.07
Equivalence :
$4,774.00

Transaction History

  • P
    Form 4
    68,200 Shares After Transaction
    Value : $167,090.00
    $20,090.00
    12/03/21
  • Footnotes:
    #1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.4492 to $2.455, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.